Bio Special WhitePaper
3 Trillion-Dollar Sectors, 2 Nations, 1 Game-Changing Deal: UK-India FTA and the Future of Life Sciences
UK-India FTA and Life Sciences: A Strategic Partnership for Growth The UK-India trade relationship has been evolving rapidly, culminating in a landmark Fr...
July 28, 2025 | Analysis
How Innovation Gaps in Biopharma Raise New Safety Concerns
The biopharmaceutical industry stands at the forefront of medical innovation and delivers remarkable advances in disease treatment and prevention. Breakthr...
July 24, 2025 | News
Asia Pacific on the Brink of a Healthcare Transformation with the Arrival of the Precision Era
The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass of innovative therapies that will redefine treatment, a...
July 22, 2025 | News
Smart Implants and the Future of Musculoskeletal Injury Treatment
While these methods are structurally effective, they cannot adapt to each patient's recovery process or provide insight into the progression of healing. Th...
July 21, 2025 | News
BioPharma in APAC: Mid-Year Report 2025 – Tracking Progress, Trends & Possibilities Ahead
As we cross the midpoint of 2025, BioPharma APAC presents this Mid-Year Report—an incisive look at emerging biopharmaceutical dynamics, key i...
July 21, 2025 | Analysis
The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
The region’s women’s digital health market is projected to grow to $ 2,295.7 million by 2030, according to Grand View Research. This surge refl...
July 17, 2025 | News
Using NLP-Driven Decision Support in Emergency Health Assistance
According to the US Department of Transportation, over 40,000 lives were lost in roadway deaths in 2023. The CDC reports that the country saw appro...
July 14, 2025 | News
No More Whisper Networks: FDA Puts Its Rejection Reasons in Writing — Publicly
FDA Embraces Radical Transparency by Publishing Complete Response Letters For Immediate Release: July 10, 2025 &nb...
July 11, 2025 | News
FDA’s Most Recent 100 Warning Letters of 2025 Signal Rising Compliance Risks Across Pharma, Biologics, Devices, Food, and Online Markets
As of July 2025, the U.S. Food and Drug Administration (FDA) has issued over 3,400 warning letters, with the most recent 100 painting a vivid pictu...
July 11, 2025 | Analysis | By BioPharma APAC Desk
FDA Finalises Guidance on Drug Development for Early Lyme Disease: A Strategic Signal for Industry Innovation
This finalised guidance serves as a blueprint for biopharmaceutical developers aiming to address early manifestations of Lyme disease—particularly ea...
July 11, 2025 | Analysis | By BioPharma APAC Desk
FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
The FDA’s recent decision to cut its workforce by 20 percent has raised concerns across the biopharma industry, with experts warning of inevitable de...
July 09, 2025 | Opinion | By Lindsay Mateo, Chief Commercial Officer at Weave Bio
Smarter Together: How Molecule GEN Transforms Cross-Functional Drug Discovery
This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...
July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI
Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
Traditional therapies often fall short in targeting these aggressive cancers with precision or safety. Can SOB100 improve drug delivery without the usual s...
July 02, 2025 | Report
The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
According to GlobeNewswire, this vital sector is projected to reach an impressive $756.59 billion by 2031, exhibiting a CAGR of 5.8% from 2024 to 2031. How...
July 02, 2025 | Report
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
